Eli Lilly is making a substantial investment in artificial intelligence to accelerate its drug discovery and research process. The initiative could boost R&D productivity and shorten development timelines, improving the prospective value of Lilly's pipeline, though the article provides no dollar amount or timing for the investment.
Eli Lilly is making a substantial investment in artificial intelligence to accelerate its drug discovery and research process. The initiative could boost R&D productivity and shorten development timelines, improving the prospective value of Lilly's pipeline, though the article provides no dollar amount or timing for the investment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.35
